The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
NSAIDs-Global Market Insights and Sales Trends 2025
Synopsis
The global NSAIDs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NSAIDs in various end use industries. The expanding demands from the Back Pain Treatment, Osteoarthritis Treatment and Other Disease Treatment,, are propelling NSAIDs market. Aspirin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ibuprofen segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NSAIDs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NSAIDs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NSAIDs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NSAIDs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NSAIDs covered in this report include Bayer, Novacap, Abbott, Pfizer, Johnson & Johnson, Cigna, Geri-Care Pharmaceuticals, Perrigo Company and Kopran, etc.
The global NSAIDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
Global NSAIDs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NSAIDs market, Segment by Type:
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Global NSAIDs market, by Application
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of NSAIDs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of NSAIDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global NSAIDs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NSAIDs in various end use industries. The expanding demands from the Back Pain Treatment, Osteoarthritis Treatment and Other Disease Treatment,, are propelling NSAIDs market. Aspirin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ibuprofen segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NSAIDs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NSAIDs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NSAIDs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NSAIDs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NSAIDs covered in this report include Bayer, Novacap, Abbott, Pfizer, Johnson & Johnson, Cigna, Geri-Care Pharmaceuticals, Perrigo Company and Kopran, etc.
The global NSAIDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
Global NSAIDs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NSAIDs market, Segment by Type:
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Global NSAIDs market, by Application
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of NSAIDs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of NSAIDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 NSAIDs Market Overview
1.1 NSAIDs Product Overview
1.2 NSAIDs Market Segment by Type
1.2.1 Aspirin
1.2.2 Ibuprofen
1.2.3 Naproxen
1.2.4 Nabumetone
1.2.5 Others
1.3 Global NSAIDs Market Size by Type
1.3.1 Global NSAIDs Market Size Overview by Type (2018-2029)
1.3.2 Global NSAIDs Historic Market Size Review by Type (2018-2023)
1.3.3 Global NSAIDs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America NSAIDs Sales Breakdown by Type (2018-2023)
1.4.2 Europe NSAIDs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific NSAIDs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America NSAIDs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa NSAIDs Sales Breakdown by Type (2018-2023)
2 Global NSAIDs Market Competition by Company
2.1 Global Top Players by NSAIDs Sales (2018-2023)
2.2 Global Top Players by NSAIDs Revenue (2018-2023)
2.3 Global Top Players by NSAIDs Price (2018-2023)
2.4 Global Top Manufacturers NSAIDs Manufacturing Base Distribution, Sales Area, Product Type
2.5 NSAIDs Market Competitive Situation and Trends
2.5.1 NSAIDs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by NSAIDs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NSAIDs as of 2022)
2.7 Date of Key Manufacturers Enter into NSAIDs Market
2.8 Key Manufacturers NSAIDs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 NSAIDs Status and Outlook by Region
3.1 Global NSAIDs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global NSAIDs Historic Market Size by Region
3.2.1 Global NSAIDs Sales in Volume by Region (2018-2023)
3.2.2 Global NSAIDs Sales in Value by Region (2018-2023)
3.2.3 Global NSAIDs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global NSAIDs Forecasted Market Size by Region
3.3.1 Global NSAIDs Sales in Volume by Region (2024-2029)
3.3.2 Global NSAIDs Sales in Value by Region (2024-2029)
3.3.3 Global NSAIDs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global NSAIDs by Application
4.1 NSAIDs Market Segment by Application
4.1.1 Back Pain Treatment
4.1.2 Osteoarthritis Treatment
4.1.3 Other Disease Treatment
4.2 Global NSAIDs Market Size by Application
4.2.1 Global NSAIDs Market Size Overview by Application (2018-2029)
4.2.2 Global NSAIDs Historic Market Size Review by Application (2018-2023)
4.2.3 Global NSAIDs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America NSAIDs Sales Breakdown by Application (2018-2023)
4.3.2 Europe NSAIDs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific NSAIDs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America NSAIDs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa NSAIDs Sales Breakdown by Application (2018-2023)
5 North America NSAIDs by Country
5.1 North America NSAIDs Historic Market Size by Country
5.1.1 North America NSAIDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America NSAIDs Sales in Volume by Country (2018-2023)
5.1.3 North America NSAIDs Sales in Value by Country (2018-2023)
5.2 North America NSAIDs Forecasted Market Size by Country
5.2.1 North America NSAIDs Sales in Volume by Country (2024-2029)
5.2.2 North America NSAIDs Sales in Value by Country (2024-2029)
6 Europe NSAIDs by Country
6.1 Europe NSAIDs Historic Market Size by Country
6.1.1 Europe NSAIDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe NSAIDs Sales in Volume by Country (2018-2023)
6.1.3 Europe NSAIDs Sales in Value by Country (2018-2023)
6.2 Europe NSAIDs Forecasted Market Size by Country
6.2.1 Europe NSAIDs Sales in Volume by Country (2024-2029)
6.2.2 Europe NSAIDs Sales in Value by Country (2024-2029)
7 Asia-Pacific NSAIDs by Region
7.1 Asia-Pacific NSAIDs Historic Market Size by Region
7.1.1 Asia-Pacific NSAIDs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific NSAIDs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific NSAIDs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific NSAIDs Forecasted Market Size by Region
7.2.1 Asia-Pacific NSAIDs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific NSAIDs Sales in Value by Region (2024-2029)
8 Latin America NSAIDs by Country
8.1 Latin America NSAIDs Historic Market Size by Country
8.1.1 Latin America NSAIDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America NSAIDs Sales in Volume by Country (2018-2023)
8.1.3 Latin America NSAIDs Sales in Value by Country (2018-2023)
8.2 Latin America NSAIDs Forecasted Market Size by Country
8.2.1 Latin America NSAIDs Sales in Volume by Country (2024-2029)
8.2.2 Latin America NSAIDs Sales in Value by Country (2024-2029)
9 Middle East and Africa NSAIDs by Country
9.1 Middle East and Africa NSAIDs Historic Market Size by Country
9.1.1 Middle East and Africa NSAIDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa NSAIDs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa NSAIDs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa NSAIDs Forecasted Market Size by Country
9.2.1 Middle East and Africa NSAIDs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa NSAIDs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer NSAIDs Products Offered
10.1.5 Bayer Recent Development
10.2 Novacap
10.2.1 Novacap Company Information
10.2.2 Novacap Introduction and Business Overview
10.2.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novacap NSAIDs Products Offered
10.2.5 Novacap Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott NSAIDs Products Offered
10.3.5 Abbott Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer NSAIDs Products Offered
10.4.5 Pfizer Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Information
10.5.2 Johnson & Johnson Introduction and Business Overview
10.5.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Johnson & Johnson NSAIDs Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 Cigna
10.6.1 Cigna Company Information
10.6.2 Cigna Introduction and Business Overview
10.6.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Cigna NSAIDs Products Offered
10.6.5 Cigna Recent Development
10.7 Geri-Care Pharmaceuticals
10.7.1 Geri-Care Pharmaceuticals Company Information
10.7.2 Geri-Care Pharmaceuticals Introduction and Business Overview
10.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Geri-Care Pharmaceuticals NSAIDs Products Offered
10.7.5 Geri-Care Pharmaceuticals Recent Development
10.8 Perrigo Company
10.8.1 Perrigo Company Company Information
10.8.2 Perrigo Company Introduction and Business Overview
10.8.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Perrigo Company NSAIDs Products Offered
10.8.5 Perrigo Company Recent Development
10.9 Kopran
10.9.1 Kopran Company Information
10.9.2 Kopran Introduction and Business Overview
10.9.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Kopran NSAIDs Products Offered
10.9.5 Kopran Recent Development
10.10 Merck Sharp & Dohme
10.10.1 Merck Sharp & Dohme Company Information
10.10.2 Merck Sharp & Dohme Introduction and Business Overview
10.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Merck Sharp & Dohme NSAIDs Products Offered
10.10.5 Merck Sharp & Dohme Recent Development
10.11 Sun Pharmaceutical Industries
10.11.1 Sun Pharmaceutical Industries Company Information
10.11.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Sun Pharmaceutical Industries NSAIDs Products Offered
10.11.5 Sun Pharmaceutical Industries Recent Development
10.12 GlaxoSmithKline
10.12.1 GlaxoSmithKline Company Information
10.12.2 GlaxoSmithKline Introduction and Business Overview
10.12.3 GlaxoSmithKline NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 GlaxoSmithKline NSAIDs Products Offered
10.12.5 GlaxoSmithKline Recent Development
10.13 Reddy Pharmaceuticals
10.13.1 Reddy Pharmaceuticals Company Information
10.13.2 Reddy Pharmaceuticals Introduction and Business Overview
10.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Reddy Pharmaceuticals NSAIDs Products Offered
10.13.5 Reddy Pharmaceuticals Recent Development
10.14 Verywell
10.14.1 Verywell Company Information
10.14.2 Verywell Introduction and Business Overview
10.14.3 Verywell NSAIDs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Verywell NSAIDs Products Offered
10.14.5 Verywell Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 NSAIDs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 NSAIDs Industrial Chain Analysis
11.4 NSAIDs Market Dynamics
11.4.1 NSAIDs Industry Trends
11.4.2 NSAIDs Market Drivers
11.4.3 NSAIDs Market Challenges
11.4.4 NSAIDs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 NSAIDs Distributors
12.3 NSAIDs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
